Videoconferencing Acceptance and Commitment Therapy With a Web App Use for Family Caregivers of People With Dementia
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Aug 25, 2022
Trial Information
Current as of May 18, 2025
Withdrawn
Keywords
ClinConnect Summary
The purpose of the pilot study is to assess the effects of an 8-week program on improving mental health in depressed family caregivers of people with dementia. The program will involve 8 weekly coach-guided videoconferencing sessions and the use of a web app based on acceptance and commitment therapy (ACT) for 8 weeks. Also, the study aims to understand these caregivers' experiences in the program, including their perspectives on the app features and contents. We aim to recruit 8-10 people for this pilot project. Outcomes regarding caregivers' mental health and ACT processes will be collect...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • community-dwelling adults (age 18 or over) who are currently taking the primary responsibility for the care of a relative with dementia living in the community
- • having at least mild depression as measured by the Patient Health Questionnaire (PHQ)-9
- • having a web-enabled device (e.g., a smartphone, a tablet, or a laptop/desktop) with the internet access at home
- Exclusion Criteria:
- • having cognitive, physical, or sensory deficits or language barriers (non-English communicator) that might impede study participation
- • receiving a psychological therapy at the time of recruitment
- • having a prior experience in acceptance and commitment therapy
- • having psychiatric hospitalizations in the previous two years
- • considering or planning to place relatives with dementia in a nursing home within 3 months
- • recent frequent hospitalizations of their relatives with dementia that might contribute to study dropout
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Patients applied
Trial Officials
Areum Han, PhD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials